| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |